Moonlake Immunotherapeutics

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$20.11

+0.11 (+0.55%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 77%

Hold 3 14%

Sell 2 9%

Price Target

Analyst Price Target -47.6% upside

Low Target $8.06

Average Target $10.54

High Target $16.98

Current Price $20.11

Current
$20.11

Target
$10.54

$8.06 $10.54 avg $16.98

Scenario Analysis

Bear Case

$8.06

-59.9%

Low target

Base Case

$10.54

-47.6%

Avg target

Bull Case

$16.98

+-15.6%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$62.75

-68.0% from high

52-Week Low

$5.95

+238.0% from low

Target vs 52W High

$10.54

-83.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%